0001937613-22-000001.txt : 20220826 0001937613-22-000001.hdr.sgml : 20220826 20220826161111 ACCESSION NUMBER: 0001937613-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220826 DATE AS OF CHANGE: 20220826 EFFECTIVENESS DATE: 20220826 FILER: COMPANY DATA: COMPANY CONFORMED NAME: InGel Therapeutics, Inc. CENTRAL INDEX KEY: 0001937613 IRS NUMBER: 882693865 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-457193 FILM NUMBER: 221205290 BUSINESS ADDRESS: STREET 1: 27 MARNEY STREET STREET 2: APARTMENT 2 CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-949-0833 MAIL ADDRESS: STREET 1: 27 MARNEY STREET STREET 2: APARTMENT 2 CITY: CAMBRIDGE STATE: MA ZIP: 02141 D 1 primary_doc.xml X0708 D LIVE 0001937613 InGel Therapeutics, Inc. 27 MARNEY STREET APARTMENT 2 CAMBRIDGE MA MASSACHUSETTS 02141 617-949-0833 DELAWARE None None Corporation true 2022 Pierre Colombe Dromel 27 Marney Street Cambridge MA MASSACHUSETTS 02141 Executive Officer Director Deepti Singh 27 Marney Street Cambridge MA MASSACHUSETTS 02141 Director Michael Young 27 Marney Street Cambridge MA MASSACHUSETTS 02141 Director Myron Spector 27 Marney Street Cambridge MA MASSACHUSETTS 02141 Director Biotechnology Decline to Disclose 06b false 2022-07-06 false true true false 0 1000000 350000 650000 false 4 0 0 0 false InGel Therapeutics, Inc. /s/ Pierre Colombe Dromel Pierre Colombe Dromel President and Chief Executive Officer 2022-08-26